{"id":474,"date":"2024-11-07T16:09:46","date_gmt":"2024-11-07T16:09:46","guid":{"rendered":"https:\/\/stemvacs.therapeuticsolutionsint.com\/?page_id=474"},"modified":"2024-11-07T16:10:38","modified_gmt":"2024-11-07T16:10:38","slug":"melanoma-stemvacs-e","status":"publish","type":"page","link":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/melanoma-stemvacs-e\/","title":{"rendered":"Melanoma &#8211; StemVacs-E"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311&#8243; custom_padding=&#8221;61px|||||&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311%22:%91%22background_color%22%93}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_text _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-47px|||||&#8221; custom_padding=&#8221;2px||0px|||&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;]<\/p>\n<p>The following list of <strong>cancer immunotherapies<\/strong> are available for licensing under <a href=\"https:\/\/patents.justia.com\/patent\/20220306994\" target=\"_blank\" rel=\"noopener\">U.S. Patent Publication No.: <span>20220306994<\/span><\/a><span>.<\/span><\/p>\n<p><strong>Chimeric Cells Comprising Dendritic Cells and Endothelial Cells Resembling Tumor Endothelium<\/strong><strong><\/strong><\/p>\n<div class=\"horizontal layout style-scope patent-result\">\n<div class=\"flex-3 style-scope patent-result\" marginright=\"\">\n<section id=\"abstract\" class=\"style-scope patent-result\">\n<div class=\"flex style-scope patent-result\">Abstract<\/div>\n<div class=\"layout horizontal style-scope patent-text\">\n<section id=\"text\" class=\"flex style-scope patent-text\"><span>\u00a0Disclosed\u00a0<\/span><g class=\"gr_ gr_16 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Grammar multiReplace\" id=\"16\" data-gr-id=\"16\">are<\/g><span>\u00a0means, methods\u00a0<\/span><g class=\"gr_ gr_17 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Punctuation only-ins replaceWithoutSep\" id=\"17\" data-gr-id=\"17\">and<\/g><span>\u00a0compositions of matter useful for\u00a0<\/span><g class=\"gr_ gr_14 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Grammar only-ins replaceWithoutSep\" id=\"14\" data-gr-id=\"14\">induction<\/g><span>\u00a0of immunological responses\u00a0<\/span><g class=\"gr_ gr_15 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Grammar multiReplace\" id=\"15\" data-gr-id=\"15\">towards<\/g><span>\u00a0tumor endothelial cells. In one embodiment the invention teaches\u00a0<\/span><g class=\"gr_ gr_18 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Grammar only-ins replaceWithoutSep\" id=\"18\" data-gr-id=\"18\">fusion<\/g><span>\u00a0of dendritic cells and cells resembling tumor endothelial cells and\u00a0<\/span><g class=\"gr_ gr_19 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Grammar only-ins replaceWithoutSep\" id=\"19\" data-gr-id=\"19\">administration<\/g><span>\u00a0of such chimeric cells as an immunotherapy for stimulation of tumor endothelial cell destruction. In other\u00a0<\/span><g class=\"gr_ gr_21 gr-alert gr_gramm gr_inline_cards gr_disable_anim_appear Punctuation only-ins replaceWithoutSep\" id=\"21\" data-gr-id=\"21\">embodiments<\/g><span>\u00a0pluripotent stem cells are utilized to generate dendritic cells, wherein said dendritic cells are fused with pluripotent stem\u00a0<\/span><g class=\"gr_ gr_22 gr-alert gr_spell gr_inline_cards gr_disable_anim_appear ContextualSpelling multiReplace\" id=\"22\" data-gr-id=\"22\">cell derived<\/g><span>\u00a0endothelial cells created in a manner to resemble tumor endothelial cells.<\/span><\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-99px|auto||auto||&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_text _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-149px|||||&#8221; custom_padding=&#8221;50px|||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<html><br \/>\n<head><br \/>\n    <script src=\"https:\/\/ajax.googleapis.com\/ajax\/libs\/jquery\/1.12.4\/jquery.min.js\"><\/script><br \/>\n    <script>\n        $(function() {\n            $('.info').hide();\n            $('#countryList').on('change', function() {\n                $('.info').hide();\n                var countryCode = $('#countryList').val();\n                $('.info.' + countryCode).show();\n            });\n        });\n    <\/script><br \/>\n<\/head><br \/>\n<body><br \/>\n<select id=\"countryList\"><option value=\"\">[Select Disease]<\/option><option value=\"2\">Melanoma<\/option><option value=\"3\">Juvenile melanoma<\/option><option value=\"4\">Lentigo maligna melanoma<\/option><option value=\"5\">Malignant melanoma<\/option><option value=\"6\">Acral-lentiginous melanoma<\/option><option value=\"7\">Amelanotic melanoma<\/option><option value=\"8\">Benign juvenile melanoma<\/option><option value=\"9\">Nodular melanoma subungal melanoma<\/option><option value=\"10\">Superficial spreading melanoma<\/option><\/select><\/p>\n<div class=\"info 2\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Melanoma  is a dangerous type of skin cancer that develops from melanocytes, the cells that produce melanin, the pigment that gives skin and hair their color.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 3\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Juvenile melanoma, also known as melanoma in children, is a rare but common skin cancer in children.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 4\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Lentigo maligna melanoma is a type of skin cancer that develops from a lentigo maligna, a precancerous condition.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 5\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Malignant melanoma, also known as melanoma, is a dangerous type of skin cancer that can develop from melanocytes, the cells that produce melanin and give skin its color.<br \/>\n<\/table>\n<\/div>\n<\/table>\n<\/div>\n<div class=\"info 6\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Acral-lentiginous melanoma is a specific type of melanoma that appears on the palms of the hands, the soles of the feet, or under the nails.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 7\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Amelanotic melanoma, these skin lesions lack melanin, the dark pigment that gives most moles and melanomas their color. Instead, amelanotic melanomas can be clear, white or skin-colored, sometimes with a slight pink, purple or red tint.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 8\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Benign juvenile melanoma  is an old term for a rare, noncancerous mole called a Spitz nevus.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 9\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Nodular melanoma subungal melanoma is a rare and aggressive form of skin cancer that can appear as a nodule under the nail.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 10\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Superficial spreading melanoma is a type of skin cancer that is the most common form of melanoma, accounting for 70\u201380% of cases.<br \/>\n<\/table>\n<\/div>\n<p><\/body><br \/>\n<\/html>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The following list of cancer immunotherapies are available for licensing under U.S. Patent Publication No.: 20220306994. Chimeric Cells Comprising Dendritic Cells and Endothelial Cells Resembling Tumor Endothelium Abstract \u00a0Disclosed\u00a0are\u00a0means, methods\u00a0and\u00a0compositions of matter useful for\u00a0induction\u00a0of immunological responses\u00a0towards\u00a0tumor endothelial cells. In one embodiment the invention teaches\u00a0fusion\u00a0of dendritic cells and cells resembling tumor endothelial cells and\u00a0administration\u00a0of such chimeric [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-474","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/comments?post=474"}],"version-history":[{"count":3,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/474\/revisions"}],"predecessor-version":[{"id":477,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/474\/revisions\/477"}],"wp:attachment":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/media?parent=474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}